Skip to main content

ADVERTISEMENT

Drug-eluting stents

Original Contribution
11/26/2014

Omar Rana, DM, MRCP;  Nimit C. Shah, MBBS, MRCP, MD;  Samuel Wilson, MRCP;  Rosie Swallow, MBBS;  Peter O‚ÄôKane, MD;  Terry Levy, BSc, MBChB

Omar Rana, DM, MRCP;  Nimit C. Shah, ...
The STOP study was performed to assess DES routine postdilatation following implantation with IVUS guidance; optimizing final DES-CSA may have long-term clinical benefits, although a randomized study is required. 
The STOP study was performed to assess DES routine postdilatation following implantation with IVUS guidance; optimizing final DES-CSA may have long-term clinical benefits, although a randomized study is required. 
The STOP study was performed to...
11/26/2014
Journal of Invasive Cardiology
Original Contribution
09/27/2014

Radoslaw Pracon, MD1;  Maksymilian P. Opolski, MD2;  Gary S. Mintz, MD3;  Jerzy Pregowski, MD4; Mariusz Kruk, MD1;  Jeffrey J. Popma, MD5;  Lazar Mandinov, MD6;  Hong Wang6;  Stephen G. Ellis, MD7; Eberhard Grube, MD8;  Keith D. Dawkins, MD6;  Gregg W. Stone, MD9;  Neil J. Weissman, MD2

Radoslaw Pracon, MD1;  Maksymilian P....
Non-uniform distribution of drug-eluting stent struts may cause uneven drug deposition associated with an adverse neointimal response and clinical events. This study assesses circumferential stent strut distribution in bare-metal (BMS, n=117)...
Non-uniform distribution of drug-eluting stent struts may cause uneven drug deposition associated with an adverse neointimal response and clinical events. This study assesses circumferential stent strut distribution in bare-metal (BMS, n=117)...
Non-uniform distribution of...
09/27/2014
Journal of Invasive Cardiology
Review
11/06/2008

Thomas Zeller, MD

Herz-Zentrum Bad Krozingen, Bad Krozingen, Germany

Thomas Zeller, MD Herz-Zentrum Bad K...
In the coronaries, the role of drug-eluting stents (DES) is already well defined. However, in the peripheral arteries very limited data exists about their potential benefit.
In the coronaries, the role of drug-eluting stents (DES) is already well defined. However, in the peripheral arteries very limited data exists about their potential benefit.
In the coronaries, the role of...
11/06/2008
Vascular Disease Management
Review
09/17/2008

Bosiers et al.

Bosiers et al.
Although the use of stents is common in other peripheral vessels, the application of stents remains highly controversial in the infrapopliteal bed (BTK). In general, infrapopliteal stent implantation is reserved for cases with a suboptimal...
Although the use of stents is common in other peripheral vessels, the application of stents remains highly controversial in the infrapopliteal bed (BTK). In general, infrapopliteal stent implantation is reserved for cases with a suboptimal...
Although the use of stents is...
09/17/2008
Vascular Disease Management
Review
09/05/2008
Drug-eluting stents (DES) were designed to prevent neointimal proliferation via the controlled release of antiproliferative agents. Two such DES have been approved for use in the United States.
Drug-eluting stents (DES) were designed to prevent neointimal proliferation via the controlled release of antiproliferative agents. Two such DES have been approved for use in the United States.
Drug-eluting stents (DES) were...
09/05/2008
Vascular Disease Management